TERM ID="NYU_TERM_1" STRING="Australia" FREQUENCY=1 START=184 END=193 LEMMA="AUSTRALIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="MS" FREQUENCY=3 START=170 END=172 LEMMA="MULTIPLE SCLEROSIS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_3" STRING="MS" FREQUENCY=3 START=580 END=582 LEMMA="MULTIPLE SCLEROSIS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_4" STRING="MS" FREQUENCY=3 START=1067 END=1069 LEMMA="MULTIPLE SCLEROSIS" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_5" STRING="TEMSO" FREQUENCY=1 START=509 END=514 LEMMA="TEMSO" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Teriflunomide" FREQUENCY=2 START=0 END=13 LEMMA="TERIFLUNOMIDE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_7" STRING="Teriflunomide" FREQUENCY=2 START=857 END=870 LEMMA="TERIFLUNOMIDE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_8" STRING="clinical trial data" FREQUENCY=1 START=963 END=982 LEMMA="CLINICAL TRIAL DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="clinical trials" FREQUENCY=1 START=492 END=507 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="de novo synthesis" FREQUENCY=1 START=415 END=432 LEMMA="DE NOVO SYNTHESIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="de novo synthesis of pyrimidine" FREQUENCY=1 START=415 END=446 LEMMA="PYRIMIDINE DE NOVO SYNTHESIS" LEMMA_FREQUENCY=1 HEAD_TERM="de novo synthesis" HEAD_LEMMA="DE NOVO SYNTHESIS"
TERM ID="NYU_TERM_12" STRING="disease progression" FREQUENCY=1 START=647 END=666 LEMMA="DISEASE PROGRESSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="first-line treatment" FREQUENCY=1 START=127 END=147 LEMMA="FIRST-LINE TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="mg/day" FREQUENCY=1 START=674 END=680 LEMMA="MG/DAY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="once-daily" FREQUENCY=1 START=255 END=265 LEMMA="ONCE-DAILY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="once-daily oral application" FREQUENCY=1 START=255 END=282 LEMMA="ORAL APPLICATION ONCE-DAILY" LEMMA_FREQUENCY=1 HEAD_TERM="oral application" HEAD_LEMMA="ORAL APPLICATION"
TERM ID="NYU_TERM_17" STRING="oral application" FREQUENCY=1 START=266 END=282 LEMMA="ORAL APPLICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="positive effects" FREQUENCY=1 START=609 END=625 LEMMA="POSITIVE EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="pyrimidine" FREQUENCY=1 START=436 END=446 LEMMA="PYRIMIDINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="regular monitoring" FREQUENCY=1 START=786 END=804 LEMMA="REGULAR MONITORING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="sclerosis Teriflunomide" FREQUENCY=1 START=44 END=67 LEMMA="SCLEROSIS TERIFLUNOMIDE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="teriflunomide" FREQUENCY=2 START=767 END=780 LEMMA="TERIFLUNOMIDE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_23" STRING="teriflunomide" FREQUENCY=2 START=1013 END=1026 LEMMA="TERIFLUNOMIDE" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_24" STRING="therapeutic effect" FREQUENCY=1 START=341 END=359 LEMMA="THERAPEUTIC EFFECT" LEMMA_FREQUENCY=1
